| Business Summary | | Guidant
Corporation
develops
emerging
therapies
for
cardiovascular
and
vascular
disease.
Guidant
offers
coronary
and
peripheral
stent
systems,
balloon
dilatation
catheters
and
related
accessories
used
for
opening
blocked
arteries;
implantable
defibrillator
systems;
implantable
pacemaker
systems
used
to
manage
slow
or
irregular
heart
rhythms,
known
as
bradycardia;
implantable
cardiac
resynchronization
therapy
for
the
treatment
of
heart
failure;
products
for
use
in
minimally
invasive
vascular
procedures,
including
the
treatment
of
abdominal
aortic
aneurysms;
products
to
perform
cardiac
surgery
procedures
known
as
off-pump
coronary
revascularization
with
endoscopic
saphenous
vein
harvesting,
and
intravascular
radiotherapy
systems
for
coronary
restenosis.
Guidant
is
a
global
company
with
principal
operations
in
the
United
States,
Western
Europe
and
Japan. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | GDT
designs,
develops,
manufactures
and
markets
therapeutic
medical
devices
for
the
treatment
of
cardiovascular
and
vascular
diseases.
For
the
six
months
ended
6/30/01,
net
sales
increased
2%
to
$1.33
billion.
Net
income
decreased
7%
to
$226.5
million.
Revenues
benefitted
from
growth
in
unit
volume
in
the
United
States
and
the
European
markets.
Earnings
were
offset
by
a
$25
million
special
charge
and
the
absence
of
a
$10.8
million
gain
from
a
litigation
settlement. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| James Cornelius, 57 Chairman | $830K | $27.5M | Ronald Dollens, 54 Pres,
CEO, | 1.1M | 356K | Keith Brauer, 52 CFO,
VP-Fin. | 454K | 6.6M | Debra Minott VP, Gen. Counsel, Sec. | -- | -- | Mark Harrold, 55 VP
of HR | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|